SB-568849 is a melanin-concentrating hormone receptor 1 (MCHR1) antagonist used for investigating the role of MCHR1 in physiological and pathological processes, particularly in the central nervous system; it inhibits MCH-induced corticotropin-releasing factor (CRF) release and demonstrates potential as a pharmacological tool for studying MCHR1-related pathways due to its high selectivity, in vivo stability, acceptable brain–blood ratio, and oral bioavailability.